| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e72837de81999e7e72cb78d59d19e28 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4525 |
| filingDate |
2013-07-12^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0d563728558eafd18b84444e8ffcd3b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f9530a284299af120e9a6d9239e1400 |
| publicationDate |
2014-01-16^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2014011949-A2 |
| titleOfInvention |
Neuroprotective cb2 receptor agonists |
| abstract |
A method of treating or preventing a neuroinflammatory and/or neurodegenerative disease in a subject by administering a pharmaceutically effective amount of a CB 2 receptor agonist is described. The CB 2 receptor agonist can be a compound according to formula I or a pharmaceutically acceptable salt thereof, with R 1 and R 2 as defined herein. Administration of the CB 2 receptor agonist activates CB 2 receptors in the microglia, and can restore syntaptic plasticity, cognition, and memory in subjects having elevated levels of amyloid-ß peptide in the brain. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021021543-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10526318-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019136331-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2019205955-B2 |
| priorityDate |
2012-07-13^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |